文献速递神经肿瘤

胶质瘤手术中术中MRI评估切除范围与检测缺血灶:术中MRI优于早期术后MRI吗?

Evaluation of the extent of resection and detection of ischemic lesions with intraoperative MRI in glioma surgery: is intraoperative MRI superior to early postoperative MRI?
PubMed 文献 · J Neurosurg · 2018-08-10

该研究回顾性分析30例胶质瘤患者(强化病灶22例、非强化病灶8例),比较术中MRI与术后24小时内早期MRI在术后反应性改变、切除范围评估及弥散加权成像(DWI)缺血灶检出上的差异。结果显示术中MRI术后反应性改变发生率更低,评估切除范围优于早期术后MRI,但缺血灶在术中MRI上易被低估(5/30 vs 16/30,p=0.003),作者建议术后早期仅补充DWI扫描。

要点

  • 术中MRI术后反应性改变发生率低于早期术后MRI,评估切除范围更优。
  • 术中MRI检出缺血灶5/30(16.7%),早期术后MRI为16/30(53.3%),差异有统计学意义(p=0.003)。
  • 作者建议术后早期仅补充DWI扫描,并注意早期术后MRI可能高估残留肿瘤。

核心结论

  • 术中MRI因术后反应性改变发生率较低,在评估强化和非强化胶质瘤切除范围方面优于早期术后MRI。
  • 但术中MRI可能漏诊缺血灶,作者建议术后早期仅补充DWI扫描。
  • 临床医生需注意早期术后MRI因术后反应性改变发生率高而可能高估残留肿瘤。

研究设计与样本

  • 回顾性分析前瞻性收集的30例胶质瘤患者数据,其中强化病灶22例、非强化病灶8例。
  • 患者术前24小时内接受术前MRI,术中行术中MRI,术后24小时内行早期术后MRI,所有神经影像均使用同一台1.5T MRI扫描仪。
  • 将术中MRI或早期术后MRI与术前MRI比较,术后反应性改变定义为术前原肿瘤位置以外的新发术后强化或T2高信号区。
  • 术后缺血通过DWI评估,比较术中MRI与早期术后MRI在术后反应性改变、切除范围评估及DWI缺血灶存在方面的差异。

主要发现

  • 强化病灶患者中,术中MRI显示新发强化8/22(36.4%),早期术后MRI显示12/22(54.5%)。
  • 非强化病灶患者中,术中MRI显示新发T2高信号区4/8(50.0%),早期术后MRI显示7/8(87.5%)。
  • 术中MRI与早期术后MRI测得的切除范围不一致者,强化病灶患者为5/22(22.7%),非强化病灶患者为3/8(37.5%)。
  • DWI检出缺血灶:术中MRI为5/30(16.7%),早期术后MRI为16/30(53.3%),p=0.003;术中MRI低估缺血灶11例。

临床怎么用

  • 作者建议术后早期仅补充DWI扫描,因为术中MRI可能漏诊缺血灶。
  • 临床医生需注意早期术后MRI因术后反应性改变发生率高而可能高估残留肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: MRI scans obtained within 48-72 hours (early postoperative MRI [epMRI]), prior to any postoperative reactive changes, are recommended for the accurate assessment of the extent of resection (EOR) after glioma surgery. Diffusion-weighted imaging (DWI) enables ischemic lesions to be detected and distinguished from the residual tumor. Prior studies, however, revealed that postoperative reactive changes were often present, even in epMRI. Although intraoperative MRI (iMRI) is widely used to maximize safe resection during glioma surgery, it is unclear whether iMRI is superior to epMRI when evaluating the EOR, because it theoretically shows fewer postoperative reactive changes. In addition, the ability to detect ischemic lesions using iMRI has not been investigated. METHODS: The authors retrospectively analyzed prospectively collected data in 30 patients with glioma (22 and 8 patients with enhancing and nonenhancing lesions, respectively) who underwent tumor resection. These patients had received preoperative MRI within 24 hours prior to surgery, postresection radiological evaluation with iMRI during surgery, and epMRI within 24 hours after surgery, with all neuroimaging performed using identical 1.5T MRI scanners. The authors compared iMRI or epMRI with preoperative MRI, and defined a postoperative reactive change as a new postoperative enhancement or T2 high-intensity area (HIA), if this lesion was outside of the preoperative original tumor location. In addition, postoperative ischemia was evaluated on DWI. The iMRI and epMRI findings were compared in terms of 1) postoperative reactive changes, 2) evaluation of the EOR, and 3) presence of ischemic lesion on DWI. RESULTS: In patients with enhancing lesions, a new enhancement was seen in 8 of 22 patients (36.4%) on iMRI and in 12 of 22 patients (54.5%) on epMRI. In patients with nonenhancing lesions, a new T2 HIA was seen in 4 of 8 patients (50.0%) on iMRI and in 7 of 8 patients (87.5%) on epMRI. A discrepancy between the EOR measured on iMRI and epMRI was noted in 5 of the 22 patients (22.7%) with enhancing lesions, and in 3 of the 8 patients (37.5%) with nonenhancing lesions. The occurrence of ischemic lesions on DWI was found in 5 of 30 patients (16.7%) on iMRI, whereas it was found in 16 of 30 patients (53.3%) on epMRI (p = 0.003); ischemic lesions were underestimated on iMRI in 11 patients. CONCLUSIONS: Overall, given the lower incidence of postoperative reactive changes on iMRI, it was superior to epMRI in evaluating the EOR in patients with glioma, both with enhancing and nonenhancing lesions. However, because ischemic lesions can be overlooked on iMRI, the authors recommend only the additional DWI scan during the early postoperative period. Clinicians need to be mindful about not overestimating the presence of residual tumor on epMRI due to the high incidence of postoperative reactive changes.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Masuda Y, Akutsu H, Ishikawa E, et al. Evaluation of the extent of resection and detection of ischemic lesions with intraoperative MRI in glioma surgery: is intraoperative MRI superior to early postoperative MRI? J Neurosurg. 2018. PMID: 30095340. doi:10.3171/2018.3.JNS172516

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。